Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Senderowicz

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Cancer Research|December 20, 1999
Flavopiridol, a protein kinase inhibitor, down-regulates hypoxic induction of vascular endothelial growth factor expression in human monocytesG Melillo, E A Sausville, K Cloud, et al.
Human Pathology|April 1, 1997
An intra-abdominal small round cell neoplasm with features of primitive neuroectodermal and desmoplastic round cell tumor and a EWS/FLI-1 fusion transcriptR L Katz, M Quezado, A M Senderowicz, et al.
The Journal of Biological Chemistry|May 27, 1994
Jasplakinolide, a cytotoxic natural product, induces actin polymerization and competitively inhibits the binding of phalloidin to F-actinM R Bubb, A M Senderowicz, E A Sausville, et al.
Hepatology (Baltimore, Md.)|May 9, 2001
Characterization of autoantibodies against uridine-diphosphate glucuronosyltransferase in patients with inflammatory liver diseasesT Bachrich, T Thalhammer, W Jäger, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 22, 2001
In vitro glucuronidation of the cyclin-dependent kinase inhibitor flavopiridol by rat and human liver microsomes: involvement of UDP-glucuronosyltransferases 1A1 and 1A9B Hagenauer, A Salamon, T Thalhammer, et al.
Cancer Research|June 11, 1999
Discovery and initial characterization of the paullones, a novel class of small-molecule inhibitors of cyclin-dependent kinasesD W Zaharevitz, R Gussio, M Leost, et al.
FEBS Letters|July 21, 1999
Identification of cytosolic aldehyde dehydrogenase 1 from non-small cell lung carcinomas as a flavopiridol-binding proteinJ B Schnier, G Kaur, A Kaiser, et al.
Life Sciences|May 26, 1998
Metabolism of the anticancer drug flavopiridol, a new inhibitor of cyclin dependent kinases, in rat liverW Jäger, B Zembsch, P Wolschann, et al.
The Journal of Biological Chemistry|July 25, 2000
Flavopiridol inhibits P-TEFb and blocks HIV-1 replicationS H Chao, K Fujinaga, J E Marion, et al.
Cancer Research|September 24, 1999
Down-regulation of cyclin D1 by transcriptional repression in MCF-7 human breast carcinoma cells induced by flavopiridolB Carlson, T Lahusen, S Singh, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Cancer Research|December 20, 1999
Flavopiridol, a protein kinase inhibitor, down-regulates hypoxic induction of vascular endothelial growth factor expression in human monocytesG Melillo, E A Sausville, K Cloud, et al.
Human Pathology|April 1, 1997
An intra-abdominal small round cell neoplasm with features of primitive neuroectodermal and desmoplastic round cell tumor and a EWS/FLI-1 fusion transcriptR L Katz, M Quezado, A M Senderowicz, et al.
The Journal of Biological Chemistry|May 27, 1994
Jasplakinolide, a cytotoxic natural product, induces actin polymerization and competitively inhibits the binding of phalloidin to F-actinM R Bubb, A M Senderowicz, E A Sausville, et al.
Hepatology (Baltimore, Md.)|May 9, 2001
Characterization of autoantibodies against uridine-diphosphate glucuronosyltransferase in patients with inflammatory liver diseasesT Bachrich, T Thalhammer, W Jäger, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 22, 2001
In vitro glucuronidation of the cyclin-dependent kinase inhibitor flavopiridol by rat and human liver microsomes: involvement of UDP-glucuronosyltransferases 1A1 and 1A9B Hagenauer, A Salamon, T Thalhammer, et al.
Cancer Research|June 11, 1999
Discovery and initial characterization of the paullones, a novel class of small-molecule inhibitors of cyclin-dependent kinasesD W Zaharevitz, R Gussio, M Leost, et al.
FEBS Letters|July 21, 1999
Identification of cytosolic aldehyde dehydrogenase 1 from non-small cell lung carcinomas as a flavopiridol-binding proteinJ B Schnier, G Kaur, A Kaiser, et al.
Life Sciences|May 26, 1998
Metabolism of the anticancer drug flavopiridol, a new inhibitor of cyclin dependent kinases, in rat liverW Jäger, B Zembsch, P Wolschann, et al.
The Journal of Biological Chemistry|July 25, 2000
Flavopiridol inhibits P-TEFb and blocks HIV-1 replicationS H Chao, K Fujinaga, J E Marion, et al.
Cancer Research|September 24, 1999
Down-regulation of cyclin D1 by transcriptional repression in MCF-7 human breast carcinoma cells induced by flavopiridolB Carlson, T Lahusen, S Singh, et al.
Pageof 4